Anthony Hunt - Dec 5, 2024 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Director
Signature
/s/ Marc Baumgartner (Attorney in Fact)
Stock symbol
RGEN
Transactions as of
Dec 5, 2024
Transactions value $
$399,937
Form type
4
Date filed
12/5/2024, 08:26 PM
Previous filing
Nov 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $400K +11.8K +8.44% $33.87 152K Dec 5, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +11.8K $0.00 8.86K Dec 5, 2024 Common Stock 11.8K $33.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 11,808 of the shares underlying this option have vested. The remaining shares vest as follows: 2,952 shares on March 1, 2025, 2,952 shares on March 1, 2026, and 2,952 shares on March 1, 2027.